Murine leukemia virus (MLV) replication monitored with fluorescent proteins

Murine leukemia virus (MLV) replication monitored with fluorescent proteins

<p>Abstract</p> <p>Background</p> <p>Cancer gene therapy will benefit from vectors that are able to replicate in tumor tissue and cause a bystander effect. Replication-competent murine leukemia virus (MLV) has been described to have potential as cancer therapeutics, how...

Full description

Bibliographic Details
Main Authors:	Bittner Alexandra, Erlwein Otto, Sliva Katja, Schnierle Barbara S
Format:	Article
Language:	English
Published:	BMC 2004-12-01
Series:	Virology Journal
Online Access:	http://www.virologyj.com/content/1/1/14

Similar Items

Murine leukemia virus (MLV) P50 protein induces cell transformation via transcriptional regulatory function
by: Charbel Akkawi, et al.
Published: (2023-09-01)

Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors
by: Thaler Sonja, et al.
Published: (2005-09-01)

The role of murine leukemia virus glycosated Gag protein in virus replication
by: Fan Hung
Published: (2011-10-01)

Selective gene silencing by viral delivery of short hairpin RNA
by: Sliva Katja, et al.
Published: (2010-09-01)

From actually toxic to highly specific – novel drugs against poxviruses
by: Schnierle Barbara, et al.
Published: (2007-01-01)

Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system.
by: Benjamin Kraus, et al.
Published: (2013-01-01)

Silvestrol Inhibits Chikungunya Virus Replication
by: Lisa Henss, et al.
Published: (2018-10-01)

Interactions of Host Proteins with the Murine Leukemia Virus Integrase
by: Barbara Studamire, et al.
Published: (2010-05-01)

Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms
by: Nitta Takayuki, et al.
Published: (2012-07-01)

Absence of detectable XMRV and other MLV-related viruses in healthy blood donors in the United States.
by: Shixing Tang, et al.
Published: (2011-01-01)

Lack of infection with XMRV or other MLV-related viruses in blood, post-mortem brains and paternal gametes of autistic individuals.
by: Carla Lintas, et al.
Published: (2011-02-01)

The Mortgage Lending Value (MLV): proposal for a new calculation procedure
by: Antonio Benvenuti, et al.
Published: (2024-04-01)

Vaccinia virus replication is not affected by APOBEC3 family members
by: Sutter Gerd, et al.
Published: (2006-10-01)

Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.
by: Melvyn W Yap, et al.
Published: (2014-03-01)

Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
by: Pierre V Maillard, et al.
Published: (2007-12-01)

In vitro assembly of xenotropic murine leukemia virus-related virus CA-NC protein
by: Rumlová Michaela, et al.
Published: (2011-06-01)

Cellular Attachment and Entry Factors for Chikungunya Virus
by: Barbara S. Schnierle
Published: (2019-11-01)

Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.
by: Peiman Hematti, et al.
Published: (2004-12-01)

Recombination between the Fostera MLV-like Strain and the Strain Belonging to Lineage 1 of Porcine Reproductive and Respiratory Syndrome Virus in Korea
by: Go-Eun Shin, et al.
Published: (2022-05-01)

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.
by: Rick S Mitchell, et al.
Published: (2004-08-01)

BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements
by: Sara El Ashkar, et al.
Published: (2014-01-01)

Effects of Moloney Leukemia Virus 10 Protein on Hepatitis B Virus Infection and Viral Replication
by: Maritza N. Puray-Chavez, et al.
Published: (2019-07-01)

Ribosome profiling of the retrovirus murine leukemia virus
by: Nerea Irigoyen, et al.
Published: (2018-01-01)

ESCRT Requirements for Murine Leukemia Virus Release
by: Christina Bartusch, et al.
Published: (2016-04-01)

Host proteins interacting with the Moloney murine leukemia virus integrase: Multiple transcriptional regulators and chromatin binding factors
by: Goff Stephen P, et al.
Published: (2008-06-01)

DNA extraction columns contaminated with murine sequences.
by: Otto Erlwein, et al.
Published: (2011-01-01)

Initial vaccination and revaccination with Type I PRRS 94881 MLV reduces viral load and infection with porcine reproductive and respiratory syndrome virus
by: Jeremy Kroll, et al.
Published: (2018-08-01)

The protein structures underlying receptor binding and membrane fusion of ecotropic murine leukemia viruses
by: Fass, Deborah, 1970
Published: (2005)

Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.
by: Natalia Makarova, et al.
Published: (2011-04-01)

Determination of pig immunity status after porcine reproductive and respiratory syndrome (PRRS) modified live virus (MLV) vaccination with ELISA and PCR technique
by: Chua, Vi Vian
Published: (2016)

Concomitant Swine Influenza A Virus Infection Alters PRRSV1 MLV Viremia in Piglets but Does Not Interfere with Vaccine Protection in Experimental Conditions
by: Patricia Renson, et al.
Published: (2021-04-01)

No Xenotropic Murine Leukemia Virus–related Virus Detected in Fibromyalgia Patients
by: Joanna Luczkowiak, et al.
Published: (2011-02-01)

No association of xenotropic murine leukemia virus-related viruses with prostate cancer.
by: William M Switzer, et al.
Published: (2011-01-01)

Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
by: Georgios Papakonstantinou, et al.
Published: (2022-02-01)

Evaluation of Intradermal PRRSV MLV Vaccination of Suckling Piglets on Health and Performance Parameters under Field Conditions
by: Georgios Maragkakis, et al.
Published: (2022-12-01)

Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses
by: Smith Robert A
Published: (2010-12-01)

Improved functionality and potency of next generation BinMLV viral vectors toward safer gene therapy
by: Dominique Van Looveren, et al.
Published: (2021-12-01)

Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
by: Arianna Moiani, et al.
Published: (2013-01-01)

The receptors for gibbon ape leukemia virus and amphotropic murine leukemia virus are not downregulated in productively infected cells
by: Eiden Maribeth V, et al.
Published: (2011-07-01)

Correction: Antibody Responses against Xenotropic Murine Leukemia Virus-Related Virus Envelope in a Murine Model
Published: (2011-01-01)